Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2007-06-29FDA Approved: FUROSEMIDE — Supplemental Application (Leading Pharma, LLC)
FDA approves a supplemental application for furosemide submitted by Leading Pharma, LLC.
-
FDA approval · 2007-06-28FDA Approved: AMLODIPINE BESYLATE — Original Application (Teva Pharmaceuticals, Inc.)
The FDA approved Teva Pharmaceuticals' amlodipine besylate as a generic product in an Original Application for indications including hyperte…
-
CLINICAL_TRIALS trial_result · 2007-06-26Clinical Trial Update: Correlation Research Study: IQ2, NcIQ and IQ101 [Phase 1]
Phase 1 clinical trial update for IQ2, NcIQ and IQ101 sponsored by Noninvasive Medical Technologies, Inc.; study lists Heart Failure, Dyspne…
-
FDA approval · 2007-06-22FDA Approved: CARDENE IV — Supplemental Application (Baxter Healthcare Corporation)
FDA approved a supplemental application to add Cardene IV (nicardipine hydrochloride) as an intravenous formulation for Baxter, expanding it…
-
FDA approval · 2007-06-21FDA Approved: PROPRANOLOL HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for propranolol hydrochloride (generic) from Hikma Pharmaceuticals USA Inc., indicating an approval …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2007-06-20FDA Approved: EXFORGE — Original Application (Novartis Pharmaceuticals Corporation)
The FDA approved EXFORGE, a fixed-dose combination of amlodipine besilate and valsartan, under an original NDA from Novartis, for the treatm…
-
FDA approval · 2007-06-12FDA Approved: TRANDOLAPRIL — Original Application (Aurobindo Pharma Limited)
FDA approved a generic version of trandolapril under an original ANDA from Aurobindo Pharma Limited.
-
FDA approval · 2007-06-12FDA Approved: TRANDOLAPRIL — Original Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' generic Trandolapril as an original ANDA, expanding access to an ACE inhibitor for hypertension.
-
CLINICAL_TRIALS research · 2007-06-08Clinical Trial Update: D2 Dopamine Receptor on Human Aldosterone-Producing Adenoma and Its Role in Aldosterone Secretion and Cell Proliferation
A clinical trial update exploring the role of D2 dopamine receptors in aldosterone-producing adenomas and how they influence aldosterone sec…
-
FDA approval · 2007-05-30FDA Approved: METOPROLOL TARTRATE — Original Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved Hikma Pharmaceuticals USA Inc.'s original ANDA for metoprolol tartrate, a generic beta-blocker used to treat cardiovascular…
-
FDA approval · 2007-05-25FDA Approved: ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for Enalapril Maleate and Hydrochlorothiazide from Dr. Reddy's Laboratories Limited, approving a gen…
-
FDA approval · 2007-05-23FDA Approved: AMLODIPINE BESYLATE — Original Application (PD-Rx Pharmaceuticals, Inc.)
FDA approved a new original-application generic amlodipine besylate tablet from PD-Rx Pharmaceuticals, Inc. Indications include hypertension…
-
FDA approval · 2007-05-22FDA Approved: ACEBUTOLOL HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for acebutolol hydrochloride from Amneal Pharmaceuticals of New York LLC.
-
CLINICAL_TRIALS trial_result · 2007-05-15Clinical Trial Update: A Study in People With Mild Hypertension [Phase 2]
A Phase 2 trial in people with hypertension sponsored by Eli Lilly has completed.
-
CLINICAL_TRIALS trial_result · 2007-05-14Clinical Trial Update: Haemodialysis Salt Reduction Study [NA]
This update reports the completion of a haemodialysis salt reduction clinical trial conducted by St George's, University of London, involvin…
-
FDA approval · 2007-05-11FDA Approved: CARTIA XT — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for CARTIA XT (diltiazem hydrochloride) from Actavis Pharma, Inc.
-
CLINICAL_TRIALS trial_result · 2007-05-10Clinical Trial Update: Doxazosin Effects on ABPM in Hypertensive Patients With Diabetic Nephropathy [Phase 4]
Phase 4 clinical trial update on doxazosin effects on ambulatory blood pressure monitoring in hypertensive patients with diabetic nephropath…
-
CLINICAL_TRIALS trial_result · 2007-05-09Clinical Trial Update: Autonomic Imbalance and 24-h Blood Pressure Change in Patients With Chronic Renal Disease
A completed clinical trial examining autonomic imbalance and 24-hour blood pressure changes in patients with chronic kidney disease.
-
CLINICAL_TRIALS research · 2007-05-08Clinical Trial Update: The Efficacy of Color-Doppler Ultrasonography to Assess the Renal Blood Flow With the Estimation of GFR
A clinical trial update evaluating color-Doppler ultrasonography to measure renal blood flow and estimate glomerular filtration rate, sponso…
-
FDA approval · 2007-05-07FDA Approved: LABETALOL HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for labetalol hydrochloride related to this product, signaling an update or expansion of its regulat…
-
FDA approval · 2007-05-01FDA Approved: TERAZOSIN — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)
FDA approved a supplemental application for Terazosin hydrochloride from Jubilant Cadista Pharmaceuticals, resulting in labeling changes.
-
CLINICAL_TRIALS trial_result · 2007-04-30Clinical Trial Update: Non-Comparative Study To Evaluate Changes In FMD After Quinapril Therapy In Hypertensive Women [Phase 4]
Phase 4, non-comparative clinical trial sponsored by Pfizer evaluated changes in flow-mediated dilation after quinapril therapy in hypertens…
-
FDA approval · 2007-04-27FDA Approved: CARDIZEM LA — Supplemental Application (Bausch Health US LLC)
The FDA approved a supplemental application for Cardizem LA (diltiazem hydrochloride extended-release) from Bausch Health US LLC.
-
CLINICAL_TRIALS trial_result · 2007-04-25Clinical Trial Update: Effects of Potassium Salts on Blood Pressure and Target Organ Damage [Phase 3]
Phase 3 study evaluating the effects of potassium salts on blood pressure and target organ damage in hypertension. Current status is unknown…
-
FDA approval · 2007-04-19FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for verapamil hydrochloride from Actavis Pharma, Inc., granting approval of a supplemental indicatio…